Patients with Type 2 Diabetes Mellitus (T2DM) complicated by Chronic Kidney Disease (CKD)
Conditions
Interventions
Observation group:None
Sponsors
The 2nd Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. T2DM patients aged 18 years or older; 2. HbA1c between 7.0% and 11.0%; 3. Waist-to-height ratio >= 0.4; 4. Clinically diagnosed with CKD (meeting the 2023 KDIGO definition of chronic kidney disease); 5. Planning to use or currently using Hengglijin; 6. Signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with drug abuse or addiction; 2. According to the judgment of the researchers, there are other unsuitable conditions for patients to join the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Normal or improved proportion of UACR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in subjects' HbA1c, FPG, and 2-hour PPG levels on a natural diet compared to baseline;Changes in subjects' UACR, eGFR, blood creatinine, urea or blood urea nitrogen, and uric acid levels compared with baseline;Changes in participants' blood routine, urine routine, liver function, blood pressure, blood lipids, and electrolyte levels compared with baseline;Changes in subjects' weight, waist circumference, BMI, and waist-to-height ratio compared to baseline;Adjustment of empagliflozin dosage;The subject's history of other medications, smoking, and alcohol consumption; | — |
Countries
China
Contacts
Public ContactYang Gangyi
The 2nd Affiliated Hospital of Chongqing Medical University
Outcome results
None listed